3-3179654-G-C
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_016302.4(CRBN):c.34C>G(p.His12Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,613,098 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H12P) has been classified as Uncertain significance.
Frequency
Consequence
NM_016302.4 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disabilityInheritance: AR Classification: MODERATE Submitted by: ClinGen
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intellectual disability, autosomal recessive 2Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152242Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000809 AC: 2AN: 247290 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1460856Hom.: 1 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726796 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74374 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.34C>G (p.H12D) alteration is located in exon 1 (coding exon 1) of the CRBN gene. This alteration results from a C to G substitution at nucleotide position 34, causing the histidine (H) at amino acid position 12 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at